Dr. Reddy's launches Divalproex Sodium ER Tablets

22 Aug 2013 Evaluate

Dr. Reddy's Laboratories has launched Divalproex Sodium Extended - Release Tablets, USP (250 mg and 500 mg), a therapeutic equivalent generic version of Depakote ER (divalproex sodium) Tablet, Extended Release in the US market on August 19, 2013. Dr. Reddy's ANDA for Divalproex Sodium Extended- Release Tablets, USP was approved by the United States Food & Drug Administration (US FDA).

The Depakote ER brand and generic had combined U.S. sales of approximately $194 Million MAT for the most recent twelve months ending in June 2013 according to IMS Health. Dr. Reddy's Divalproex Sodium Extended - Release Tablets, USP 250 mg are available in bottle count sizes of 100 and 500 mg are available in bottle count sizes of 100 and 500.

Dr Reddy's is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.

Dr. Reddys Lab Share Price

1255.45 1.85 (0.15%)
02-Jan-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1730.30
Dr. Reddys Lab 1255.45
Cipla 1511.70
Zydus Lifesciences 917.00
Lupin 2108.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×